SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 11.56% in the revenue at Rs. 601.40 millions was reported in the December 2022 quarter as compared to Rs. 539.10 millions during year-ago period.Net Profit recorded in the quarter ended December 2022 rise to 47.14% to Rs. 77.85  millions  compared to R. 52.91 millions in corresponding previous quarter.The company reported a good operating profit of 103.75 millions compared to 78.58 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 601.40 539.10 11.56 1812.63 1663.58 8.96 2260.97 1879.46 20.30
Other Income 17.41 19.54 -10.90 31.75 30.61 3.72 33.36 43.93 -24.06
PBIDT 103.75 78.58 32.03 311.28 276.42 12.61 291.31 234.72 24.11
Interest 1.77 0.58 205.17 2.17 2.26 -3.98 2.85 5.14 -44.55
PBDT 101.98 78.00 30.74 251.07 274.16 -8.42 288.46 229.58 25.65
Depreciation 3.30 3.70 -10.81 7.27 8.81 -17.48 15.26 10.86 40.52
PBT 98.68 74.30 32.81 243.80 265.35 -8.12 273.20 218.72 24.91
TAX 20.83 21.39 -2.62 58.15 78.30 -25.73 77.32 48.14 60.61
Deferred Tax 10.13 4.46 127.13 6.88 3.35 105.37 0.00 0.00 0.00
PAT 77.85 52.91 47.14 185.65 187.05 -0.75 195.88 170.58 14.83
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 17.25 14.58 18.35 17.17 16.62 3.35 12.88 12.49 3.17

Jagsonpal Pharma Share Price

206.50 -3.80 (-1.81%)
04-May-2026 12:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.25
Dr. Reddys Lab 1290.95
Cipla 1328.40
Zydus Lifesciences 901.20
Lupin 2350.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×